Whole-body hyperthermia with water-filtered infrared radiation: technical-physical aspects and clinical experiences
- PMID: 11212877
- DOI: 10.1080/02656730150201561
Whole-body hyperthermia with water-filtered infrared radiation: technical-physical aspects and clinical experiences
Abstract
Among the different methods of whole-body hyperthermia (WBH), the energy transfer with infrared radiation seems to have established itself as a relatively simple procedure. The infrared systems differ with regard to the used spectrum of radiation. In the case of water-filtered infrared radiation, infrared A (760-1400 nm) is the focal point of heat radiation. This radiation penetrates deep into the skin up to the capillary area of the corium. Eighty treatments of patients in an advanced stage of cancer (40 male, 40 female, April 1998-April 1999) were performed with a WBH device with water-filtered infrared radiation, IRATHERM 2000. Extreme WBH was combined with induced hyperglycaemia and relative hyperoxaemia, and for 83% of the patients with chemotherapy as well. The body-core temperature was measured rectally (85%) or vesically. The objectives of the thermal control were a low rate of side-effects and a quick rise of the body-core temperature with regard to the condition of the patient's skin. The mean duration of the rising phase (37.5-41.5 degrees C) was 87 +/- 19 min. A correlation between lamp power and rising time (r = 0.08) was not found. Moreover, no correlation could be found between the appearance of thermal lesions > or = WHO 2nd degree and the lamp power. Thermal lesions according to WHO 1st, 2nd and 3rd degrees appeared in the case of 20, 15 and one treatment, respectively. Their area amounted in 2nd-degree cases to 0.08% of the body surface, on average. The highest mean temperature over 60 min (T60) was 42.1 +/- 0.1 degrees C, and the mean of maximum temperature (Tmax) was 42.3 +/- 0.1 degrees C. The mean thermal isoeffect dose EM43 was 35.8 +/- 6.3 min. WBH with water-filtered infrared radiation in combination with induced hyperglycaemia and relative hyperoxaemia (procedure of systemic Cancer Multistep Therapy) is a safe and practicable procedure with good tolerability in the case of experienced application. It permits a rapid rise of body-core temperature and a high thermal constancy in the plateau phase. An all-around access to the patient is possible in all therapy phases.
Similar articles
-
Evaluation of systemic tolerance of 42.0 degrees C infrared-A whole-body hyperthermia in combination with hyperglycemia and hyperoxemia. A Phase-I study.Strahlenther Onkol. 1994 Jun;170(6):322-34. Strahlenther Onkol. 1994. PMID: 8023241 Clinical Trial.
-
Principles and concept 1993 of the Systemic Cancer Multistep Therapy (sCMT). Extreme whole-body hyperthermia using the infrared-A technique IRATHERM 2000--selective thermosensitisation by hyperglycemia--circulatory back-up by adapted hyperoxemia.Strahlenther Onkol. 1994 Oct;170(10):581-9. Strahlenther Onkol. 1994. PMID: 7974169
-
Feasibility and analysis of thermal parameters for the whole-body-hyperthermia system IRATHERM-2000.Int J Hyperthermia. 2000 Jul-Aug;16(4):325-39. doi: 10.1080/02656730050074096. Int J Hyperthermia. 2000. PMID: 10949129 Clinical Trial.
-
Current status of radiant whole-body hyperthermia at temperatures >41.5 degrees C and practical guidelines for the treatment of adults. The German 'Interdisciplinary Working Group on Hyperthermia'.Int J Hyperthermia. 2005 Mar;21(2):169-83. doi: 10.1080/02656730400003401. Int J Hyperthermia. 2005. PMID: 15764358 Review.
-
Heat for wounds - water-filtered infrared-A (wIRA) for wound healing - a review.Ger Med Sci. 2016 Jun 29;14:Doc08. doi: 10.3205/000235. eCollection 2016. Ger Med Sci. 2016. PMID: 27408610 Free PMC article. Review.
Cited by
-
New experimental model for single liver lobe hyperthermia in small animals using non-directional microwaves.PLoS One. 2017 Sep 21;12(9):e0184810. doi: 10.1371/journal.pone.0184810. eCollection 2017. PLoS One. 2017. PMID: 28934251 Free PMC article.
-
Therapeutic Potential of Infrared and Related Light Therapies in Metabolic Diseases.Int J Mol Sci. 2025 May 27;26(11):5134. doi: 10.3390/ijms26115134. Int J Mol Sci. 2025. PMID: 40507946 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous